E-Mail
IMAGE: Alyssa Brunal, a recent graduate of Virginia Tech s translational biology, medicine, and health doctoral program, and Yuchin Albert Pan, an associate professor at Fralin Biomedical Research Institute, discovered a link. view more
Credit: Virginia Tech
For the brain to learn, retain memories, process sensory information, and coordinate body movements, its groups of nerve cells must generate coordinated electrical signals. Disorder in synchronous firing can impair these processes and, in extreme cases, lead to seizures and epilepsy.
Synchrony between neighboring neurons depends on the protein connexin 36, an essential element of certain types of synaptic connections that, unlike classical chemical synapses, pass signals between neurons through direct electrical connections. For more than 15 years, scientists have debated the tie between connexin 36 and epilepsy.
CIT Announces Inaugural Solicitation for the New Commonwealth Commercialization Fund
Up to $7 million in non-dilutive funding available for Virginia companies
Richmond, VA, Jan. 07, 2021 (GLOBE NEWSWIRE) The Center for Innovative Technology (CIT) announced today its Request for Proposals (RFP) for the first solicitation under the newly formed Commonwealth Commercialization Fund (CCF).
The CCF was launched on July 1, 2020 to foster innovative and collaborative commercialization efforts in Virginia, consolidating two legacy programs: the Commonwealth Research Commercialization Fund (CRCF) and the Virginia Research Investment Fund (VRIF). In FY2021, CIT is conducting a single CCF solicitation for young Virginia companies that have strong potential to drive economic growth in Virginia, including through revenue and job creation. Up to $7 million is available to award; a one-to-one match is required.